Graphite Bio Inc.

NASDAQ: GRPH · Real-Time Price · USD
3.18
-0.09 (-2.75%)
At close: Mar 21, 2024, 9:00 PM

Graphite Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
5M n/a -10.24M n/a n/a n/a 10.24M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a 942K n/a n/a n/a 142K 800K 2.1M 2.22M 2.22M 2.17M 2.06M n/a n/a n/a n/a n/a
Gross Profit
n/a n/a -9.29M n/a n/a n/a 10.09M -800K -2.1M -2.22M -2.22M -2.17M -2.06M n/a n/a n/a n/a n/a
Operating Income
-16.86M -16.93M -15.22M -25.28M -14.35M -16.09M -14.6M -25.03M -58.16M -26.45M -26.75M -26.15M -26.78M -25.96M -18.94M -14.6M -17.53M -9.37M
Interest Income
2.25M 2.32M 2.57M 2.74M 2.46M 788K 2.56M 2.96M 2.85M 2.59M 2.15M 1.47M n/a n/a n/a n/a n/a n/a
Pretax Income
-14.41M -14.62M -12.65M -35.15M -10.25M -16.65M -22.92M -22.48M -55.31M -23.93M -24.6M -24.68M -25.94M -25.84M -18.93M -14.59M -17.53M -19.71M
Net Income
-14.91M -14.62M 12.28M -10.21M -10.25M -16.65M -22.92M -22.48M -55.31M -21.42M -22.45M -23.21M -25.1M -25.71M -18.93M -14.59M -17.53M -19.71M
Selling & General & Admin
12.8M 11.11M 2.5M 6.49M 7.41M 5.55M 14.46M 11.29M 7.46M 7.62M 8.29M 7.85M 9M 7.71M 7.74M 5.92M 4.87M 3.99M
Research & Development
9.06M 5.82M 16.88M 6.45M 6.95M 10.54M 1K 2.38M 13.51M 16.24M 18.46M 18.3M 17.78M 18.25M 11.21M 8.68M 12.67M 5.38M
Other Expenses
n/a n/a n/a n/a n/a n/a 75K 11.35M 37.2M 2.58M n/a n/a 840K 123K 10K 10K 4K n/a
Operating Expenses
21.86M 16.93M 19.37M 12.95M 14.35M 16.09M 14.46M 25.03M 20.96M 23.87M 26.75M 26.15M 26.78M 25.96M 18.94M 14.6M 17.53M 9.37M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a 5.24M 2.15M 1.47M n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a 142K n/a n/a n/a -142K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
n/a n/a 20.32M n/a n/a 16.09M 14.6M 25.03M 20.96M 23.87M 26.75M 26.15M 26.78M 25.96M 18.94M 14.6M 17.53M 9.37M
Income Tax Expense
500K n/a 31.84M n/a n/a n/a n/a n/a n/a -2.52M -2.15M -1.47M -840K -123K n/a 10K 4K n/a
Shares Outstanding (Basic)
28.08M 27.53M 21.28M 27.17M 25.61M 23.59M 24.86M 24.54M 24.32M 23.94M 23.88M 23.66M 23.39M 23.15M 22.9M 22.62M 15.26M 23.35M
Shares Outstanding (Diluted)
28.08M 27.53M 21.28M 27.17M 25.61M 23.59M 24.86M 24.54M 24.32M 23.94M 23.88M 23.66M 23.39M 23.15M 22.9M 22.62M 15.26M 23.35M
EPS (Basic)
-0.53 -0.53 1.97 -0.38 -0.4 -3.53 -2.77 -2.75 -6.82 -2.68 -2.82 -2.94 -3.22 -3.33 -2.48 -1.94 -3.45 -2.53
EPS (Diluted)
-0.53 -0.53 1.97 -0.38 -0.4 -3.53 -2.77 -2.75 -6.82 -2.68 -2.82 -2.94 -3.22 -3.33 -2.48 -1.94 -3.45 -2.53
EBITDA
-16.86M -16.93M 43.21M -12.95M -14.35M -16.09M -14.46M -1.57M 17.08M -20.56M -26.07M -25.5M -26.2M -25.52M -18.93M -14.39M -17.41M -9.28M
EBIT
n/a n/a 17.2M n/a n/a -16.09M -17.2M n/a n/a -18.7M -22.45M -23.21M -26.78M -25.96M n/a -14.6M -17.53M -9.37M
Depreciation & Amortization
n/a n/a -909K n/a n/a 5K 142K 762K 849K 5.89M 682K 652K 578K 440K 330K 198K 116K 90K